An ever-changing world of reimbursement can be frustrating for those involved in revenue cycle management (RCM). Being too set in your ways to change, however, is one of the most common strategic mistakes seen by Nicole Rogas, MBA, senior vice president of sales at Experian Health.

This year at the HFMA Annual National Institute, Deloitte will be showcasing its suite of provider margin improvement analytics services and products. This family of products for health care providers includes the ConvergeHEALTH Provider Intellect suite and LaborWise, Deloitte's workforce-focused analytics solution that identifies labor overspend.

Whether Republicans’ version of an Affordable Care Act repeal-and-replace bill looks like the House-passed American Health Care Act (AHCA) or the Senate’s Better Care Reconciliation Act (BCRA), it would have a negative impact on the credit ratings of nonprofit hospitals, according to Fitch Ratings.

Transitioning to value-based care and taking on risk is often cited as one of the drivers of the consolidation trend throughout healthcare. Some systems, however, are beginning to look at partnerships more “holistically,” according to Kaufman Hall managing director Anu Singh, MBA, by pursuing creative affiliations to enhance their capabilities rather than a merger or acquisition.

In a year with new payment tracks for Medicare, additional bumps in the road on the path to value-based care and—potentially—an overhaul of health insurance coverage coming through Congress, what are healthcare finance leaders going to be focused on at this year’s conference?

Predictive modeling has been shown to help providers assess patient risk for a variety of conditions—which is how the vast majority of hospitals and health systems have been utilizing it.

Advising patients on decision making with input based on evidence should be the minimum for primary care physicians. But according to a new BMJ study, only 18 percent of clinical recommendations are based on high-quality evidence.

Advanced Sterilization Products (ASP) have received clearance from the U.S. Food and Drug Administration for the STERRAD VELOCITY Biological Indicator (BI) System. This system, which tests tools for proper sterilization, is able to cut time when receiving test results from hours to 30 minutes.